Serum cortisol in HIV-infected patients with and without highly active antiretroviral therapy

AIDS

Volumn 17, Issue 1, 2003, Pages 123-126

  Collazos, Julio ^a   Mayo, Jose ^a   Martínez, Eduardo ^a   Ibarra, Sofía ^a  

^a HOSPITAL DE GALDAKAO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL;

ADRENOCORTICAL HYPERFUNCTION; ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; HYDROCORTISONE; LINEAR MODELS; MALE; PROSPECTIVE STUDIES;

EID: 0037415025     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200301030-00018     Document Type: Article

References (14)

1. Membreno L, Irony I, Dere W, Klein R, Biglieri EG, Cobb E. Adrenocortical function in acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1987; 65:482-487.
2. Villette JM, Bourin P, Doinel C, Mansour I, Fiet J, Boudou P, et al. Circadian variations in plasma levels of hypophyseal, adrenocortical and testicular hormones in men infected with human immunodeficiency virus. J Clin Endocrinol Metab 1990; 70:572-577.
3. Merenich JA, McDermott MT, Asp AA, Harrison SM, Kidd GS. Evidence of endocrine involvement early in the course of human immunodeficiency virus infection. J Clin Endocrinol Metab 1990; 70:566-571.
4. Kertzner RM, Goetz R, Todak G, Cooper T, Lin SH, Reddy MM, et al. Cortisol levels, immune status, and mood in homosexual men with and without HIV infection. Am J Psychiatry 1993; 150:1674-1678.
5. Findling JW, Buggy BP, Gilson IH, Brummitt CF, Bernstein BM, Raft H. Longitudinal evaluation of adrenocortical function in patients infected with the human immunodeficiency virus. J Clin Endocrinol Metab 1994; 79:1091-1096.
6. Verges B, Chavanet P, Desgres J, Vaillant G, Waldner A, Brun JM, et al. Adrenal function in HIV infected patients. Acta Endocrinol (Copenh) 1989; 121:633-637.
7. Christeff N, Gharakhanian S, Thobie N, Rozenbaum W, Nunez EA. Evidence for changes in adrenal and testicular steroids during HIV infection. J Acquir Immune Defic Syndr 1992; 5:841-846.
8. Christeff N, Melchior JC, de Truchis P, Perronne C, Nunez EA, Gougeon ML. Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: correlation between dyslipidaemia and steroid hormone alterations. AIDS 1999; 13:2251-2260.
9. Yanovski JA, Miller KD, Kino T, Friedman TC, Chrousos GP, Tsigos C, et al. Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated llpodystrophy. J Clin Endocrinol Metab 1999; 84:1925-1931.
10. Eagling VA, Back DJ, Barry MG. Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavlr, saquinavir and indinavir. Br J Clin Pharmacol 1997; 44:190-194.
11. Inaba T, Fischer NE, Riddick DS, Stewart DJ, Hidaka T. HIV protease inhibitors saquinavir, indinavir and ritonavir: inhibition of CYP3A4-mediated metabolism of testosterone and benzoxazinorifamycin, KRM-1648, in human liver microsomes. Toxicol Lett 1997; 93:215-219.
12. Saint-Marc T, Partisani M, Poizot-Martin I, Bruno F, Rouviere O, Lang JM, et al. A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy. AIDS 1999; 13:1659-1667.
13. Sustiva Product Information. Wilmington, Delaware: DuPont Pharmaceuticals Company; 2000.
14. Collazos J, Mayo J, Martínez E, Ibarra S. Association between sexual disturbances and sexual hormones with specific antiretroviral drugs. AIDS 2002; 16:1294-1295.